Prediction of survival in glioma patients by means of positron emission tomography. Academic Article uri icon

Overview

abstract

  • The aim of this study was to determine whether positron emission tomography (PET) with fluorine-18 (18F)-2-deoxyglucose (FDG) can be used as a prognostic test in patients with high-grade cerebral gliomas, regardless of the treatment given. Forty-five patients with astrocytoma Grade III or IV were included in this analysis. The mean survival time of patients with tumors exhibiting high glucose utilization as determined by PET-FDG was 5 months, whereas patients with gliomas showing lower glucose utilization had a mean survival period of 19 months. It is postulated that PET-FDG scans reflect the biological behavior of high-grade astrocytomas and may be used to predict the survival time of patients harboring such neoplasms.

publication date

  • June 1, 1985

Research

keywords

  • Brain Neoplasms
  • Glioblastoma
  • Tomography, Emission-Computed

Identity

Digital Object Identifier (DOI)

  • 10.3171/jns.1985.62.6.0816

PubMed ID

  • 2987440

Additional Document Info

volume

  • 62

issue

  • 6